Trademark: 97782706
Word
FORTREA
Status
Pending
Status Code
681
Status Date
Wednesday, April 24, 2024
Serial Number
97782706
Mark Type
3
Filing Date
Monday, February 6, 2023
Published for Opposition
Tuesday, May 28, 2024

Trademark Owner History
FORTREA INC. - 1st New Owner Before Publication
Labcorp Drug Development Inc. - Original Applicant

Classifications
35 Business consulting, management, and planning services in the field of clinical trials; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval and post-approval actions related to drugs and medical devices; economic forecasting and analysis in the field of pharmaceutical, biotechnology, and medical device industries; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business management services, namely, supply and demand forecasting in connection with drug supplies for clinical trials; recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients and volunteers for participation in clinical trials for the testing of drugs; business administration of patient reimbursement programs; business advisory services, business consultancy services, business data analysis, business information services, business management consulting, business strategy development services, market intelligence services, market research, marketing services, electronic data collection and data submission services for business purposes, database management, business project management services all in the fields of clinical trials and post approval pharmaceuticals, medical devices, and biotechnology; market research and business marketing consulting services in the fields of international health and pharmaceutical, biotechnology, and medical device industries; market analysis in the field of international health and in the pharmaceutical, biotechnology, and medical device industries; providing business and statistical information for business purposes and data processing services, all in the field of international health and in the pharmaceutical, biotechnology, and medical device industries
44 Medical services in the field of pharmacology and specimen collection and procedures in connection with clinical trials; providing an online computer database featuring medical information in the field of patient management and outcomes; providing a website featuring medical information in the fields of clinical trials and patient management and outcomes; medical and pharmaceutical consultation
42 Pharmaceutical drug development services; design and testing of new products, namely, medical devices, for others; research and development in the fields of pharmaceuticals, medical devices, and biotechnology; medical and scientific research in the field of clinical trials, namely, designing, organizing, conducting, monitoring, and managing clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of design, planning, and implementation project management of clinical trials and studies on pharmaceuticals and medical devices; providing temporary use of online non-downloadable software for the collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory services, namely, formulating and bioprocessing pharmaceuticals; rental of laboratory apparatus and instruments;Maintenance, development and updating of computer software in the field of pharmaceutical drug development and medical device testing services; database design and development in the field of pharmaceutical drug development and medical device testing services; design and development of software for use in conducting research in pharmaceutical and medical device development studies; providing online computer databases in the fields of research and development of pharmaceuticals, medical devices, and biotechnology; data mining in the fields of research and development of pharmaceuticals, medical devices, and biotechnology; providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from clinical trials and studies on pharmaceuticals and medical devices; advisory services for others in the field of pharmaceutical drug development; providing medical and scientific research information in the fields of biochemistry, pharmaceuticals and clinical trials; providing online non-downloadable software for tracking, monitoring, analyzing, generating and reporting information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; application service provider (ASP) featuring software for use in database and record management in the fields of clinical trials and post-approval research for pharmaceuticals and medical devices; providing temporary use of online non-downloadable software for collecting, organizing, and reporting clinical trial information and trial results; providing temporary use of online non-downloadable software for uploading and accessing test results in the field of medical testing for scientific research purposes; providing temporary use of online non-downloadable software for storing, retrieving, accessing, displaying, managing, analyzing, and reviewing information and data in the fields of pharmaceuticals, medical devices, and biotechnology; scientific study and research in the field of production of chemicals, pharmaceuticals and medical devices; providing online non-downloadable software for planning, managing and supporting clinical trials; medical and scientific clinical research for others in the field of the production of pharmaceuticals, biopharmaceuticals, and medical devices; software as a service (SAAS) services, namely, hosting software for use by others for the collection, review, analysis, and reporting of clinical trial and drug development information; technical support services, namely, troubleshooting of computer software problems for software and hosted software applications used in connection with clinical trials and drug development; research and development in the field of pharmaceuticals, biopharmaceuticals, medical devices, and medical diagnostics; clinical research in the field of production of chemicals, pharmaceuticals, medical devices and medical diagnostics; providing interactive web sites featuring technology that enables users to collect, review, analyze and report on clinical research and drug development information; providing temporary use of online non-downloadable software to allow users to collect, review, analyze and report on clinical research and drug development
The mark consists of the design of one circle, below and to the right appears a slanted quadrilateral that fades in clarity from top to bottom, below and to the right of this is an identical circle with an elongated quadrilateral extending from the circle that fades in clarity from bottom to top. To the right of this design appears the wording "FORTREA" in a stylized font.
Color is not claimed as a feature of the mark.

Trademark Events
Feb 9, 2023
New Application Entered
Feb 24, 2023
New Application Office Supplied Data Entered
Feb 25, 2023
Notice Of Design Search Code E-Mailed
Jun 7, 2023
Automatic Update Of Assignment Of Ownership
Nov 2, 2023
Assigned To Examiner
Nov 9, 2023
Non-Final Action Written
Nov 9, 2023
Non-Final Action E-Mailed
Nov 9, 2023
Notification Of Non-Final Action E-Mailed
Dec 14, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 14, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 14, 2023
Teas Change Of Correspondence Received
Jan 17, 2024
Teas Response To Office Action Received
Jan 17, 2024
Correspondence Received In Law Office
Jan 18, 2024
Teas/Email Correspondence Entered
Apr 19, 2024
Examiners Amendment -Written
Apr 19, 2024
Examiners Amendment E-Mailed
Apr 19, 2024
Notification Of Examiners Amendment E-Mailed
Apr 19, 2024
Examiner's Amendment Entered
Apr 19, 2024
Approved For Pub - Principal Register
May 8, 2024
Notification Of Notice Of Publication E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24